MDMA (US Medical Device Manufacturers Association) fury over US "industry" user fee move
This article was originally published in Clinica
A last-minute attempt to negotiate user fees to help pay for the FDA's medical device reviews could spark a war within the industry. The US Medical Device Manufacturers Association (MDMA) issued a blistering indictment of its industry rival, AdvaMed, the Advanced Medical Technology Association, for allegedly claiming that it represented the industry in trying to broker a user fee deal.
You may also be interested in...
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.
Butterfly Network’s CEO Laurent Faracci outlines the company’s growth strategy and plans for their “ultrasound-on-a-chip” technology after its merger with blank check company Longview Acquisition Corp. See what the company’s CEO said about it here.
CDC’s Advisory Committee on Immunization Practices votes 13-1 that these two groups be first in line for vaccination once FDA authorizes a vaccine and ACIP recommends it. Goal of vote is to guide health departments in placing vaccine orders.